MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation

Nature Structural and Molecular Biology

Volumn 21, Issue 11, 2014, Pages 981-989

  Chen, Hongshan ^a   Ruiz, Penelope D ^a   Novikov, Leonid ^a   Casill, Alyssa D ^a   Park, Jong Woo ^a,b   Gamble, Matthew J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; HISTONE H2A; HISTONE H2B; MACROHISTONE H2A1.1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; UNCLASSIFIED DRUG; BONE SIALOPROTEIN (35-62), HUMAN; CHROMATIN; HISTONE; ISOPROTEIN; MACROH2A HISTONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROTEIN BINDING; SIALOGLYCOPROTEIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; RNA SEQUENCE; TRANSCRIPTION REGULATION; ACETYLATION; BINDING SITE; FETUS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE; TUMOR CELL LINE;

ACETYLATION; BINDING SITES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CHROMATIN; FETUS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; LUNG; PEPTIDE FRAGMENTS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; PROTEIN ISOFORMS; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84908875248     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2903     Document Type: Article

References (56)

1. Cantario, N., Douet, J. &Buschbeck, M. MacroH2A: an epigenetic regulator of cancer. Cancer Lett. 336, 247-252 (2013).
2. Creppe, C., Posavec, M., Douet, J. &Buschbeck, M. MacroH2A in stem cells: a story beyond gene repression. Epigenomics 4, 221-227 (2012).
3. Gamble, M.J. &Kraus, W.L. Multiple facets of the unique histone variant macroH2A: from genomics to cell biology. Cell Cycle 9, 2568-2574 (2010).
4. Karras, G.I. et al. The macro domain is an ADP-ribose binding module. EMBO J. 24, 1911-1920 (2005).
5. Gibson, B.A. &Kraus, W.L. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell Biol. 13, 411-424 (2012).
6. Timinszky, G. et al. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat. Struct. Mol. Biol. 16, 923-929 (2009).
7. Gottschalk, A.J. et al. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc. Natl. Acad. Sci. USA 106, 13770-13774 (2009).
8. Ahel, D. et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325, 1240-1243 (2009).
9. Gottschalk, A.J., Trivedi, R.D., Conaway, J.W. &Conaway, R.C. Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1PARP1nucleosome intermediate. J. Biol. Chem. 287, 43527-43532 (2012).
10. Novikov, L. et al. QKI-mediated alternative splicing of the histone variant MacroH2A1 regulates cancer cell proliferation. Mol. Cell. Biol. 31, 4244-4255 (2011).
11. Kustatscher, G., Hothorn, M., Pugieux, C., Scheffzek, K. &Ladurner, A.G. Splicing regulates NAD metabolite binding to histone macroH2A. Nat. Struct. Mol. Biol. 12, 624-625 (2005).
12. Sporn, J.C. et al. Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene 28, 3423-3428 (2009).
13. Sporn, J.C. &Jung, B. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer. Am. J. Pathol. 180, 2516-2526 (2012).
14. Kapoor, A. et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468, 1105-1109 (2010).
15. Dardenne, E. et al. Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness. Nat. Struct. Mol. Biol. 19, 1139-1146 (2012).
16. Costanzi, C. &Pehrson, J.R. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393, 599-601 (1998).
17. Hernndez-Muoz, I. et al. Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase. Proc. Natl. Acad. Sci. USA 102, 7635-7640 (2005).
18. Gamble, M.J., Frizzell, K.M., Yang, C., Krishnakumar, R. &Kraus, W.L. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev. 24, 21-32 (2010).
19. Changolkar, L.N. &Pehrson, J.R. macroH2A1 histone variants are depleted on active genes but concentrated on the inactive X chromosome. Mol. Cell. Biol. 26, 4410-4420 (2006).
20. Ouararhni, K. et al. The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity. Genes Dev. 20, 3324-3336 (2006).
21. Doyen, C.M. et al. Mechanism of polymerase II transcription repression by the histone variant macroH2A. Mol. Cell. Biol. 26, 1156-1164 (2006).
22. Changolkar, L.N. et al. Developmental changes in histone macroH2A1-mediated gene regulation. Mol. Cell. Biol. 27, 2758-2764 (2007).
23. Changolkar, L.N., Singh, G. &Pehrson, J.R. macroH2A1-dependent silencing of endogenous murine leukemia viruses. Mol. Cell. Biol. 28, 2059-2065 (2008).
24. Buschbeck, M. et al. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol. 16, 1074-1079 (2009).
25. Cong, R. et al. macroH2A1 histone variant represses rDNA transcription. Nucleic Acids Res. 42, 181-192 (2014).
26. Kim, J.-M., Heo, K., Choi, J., Kim, K. &An, W. The histone variant MacroH2A regulates Ca2+ influx through TRPC3 and TRPC6 channels. Oncogenesis 2, e77 (2013).
27. Choo, J.H., Do Kim, J. &Kim, J. MacroH2A1 knockdown effects on the Peg3 imprinted domain. BMC Genomics 8, 479 (2007).
28. Bernstein, B.E. et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat. Biotechnol. 28, 1045-1048 (2010).
29. Rappa, F. et al. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma. PLoS ONE 8, e54458 (2013).
30. Hottiger, M.O., Hassa, P.O., Lscher, B., Schler, H. &Koch-Nolte, F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 35, 208-219 (2010).
31. Eltze, T. et al. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors. Mol. Pharmacol. 74, 1587-1598 (2008).
32. Kraus, W.L. &Hottiger, M.O. PARP-1 and gene regulation: progress and puzzles. Mol. Aspects Med. 34, 1109-1123 (2013).
33. Hassa, P.O. et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-'B-dependent transcription. J. Biol. Chem. 280, 40450-40464 (2005).
34. Hassa, P.O., Buerki, C., Lombardi, C., Imhof, R. &Hottiger, M.O. Transcriptional coactivation of nuclear factor-'B-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J. Biol. Chem. 278, 45145-45153 (2003).
35. Abell, A.N. et al. MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell 8, 525-537 (2011).
36. Bowers, E.M. et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem. Biol. 17, 471-482 (2010).
37. Bernstein, E. et al. A phosphorylated subpopulation of the histone variant macroH2A1 is excluded from the inactive X chromosome and enriched during mitosis. Proc. Natl. Acad. Sci. USA 105, 1533-1538 (2008).
38. Briggs, S.D. et al. Gene silencing: trans-histone regulatory pathway in chromatin. Nature 418, 498 (2002).
39. Sun, Z.-W. &Allis, C.D. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418, 104-108 (2002).
40. Shia, W.-J., Li, B. &Workman, J.L. SAS-mediated acetylation of histone H4 Lys 16 is required for H2A.Z incorporation at subtelomeric regions in Saccharomyces cerevisiae. Genes Dev. 20, 2507-2512 (2006).
41. Krishnakumar, R. et al. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319, 819-821 (2008).
42. Krishnakumar, R. &Kraus, W.L. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol. Cell 39, 736-749 (2010).
43. Messner, S. et al. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res. 38, 6350-6362 (2010).
44. Martinez-Zamudio, R. &Ha, H.C. Histone ADP-ribosylation facilitates gene transcription by directly remodeling nucleosomes. Mol. Cell. Biol. 32, 2490-2502 (2012).
45. Schiltz, R.L. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274, 1189-1192 (1999).
46. Bedford, D.C., Kasper, L.H., Fukuyama, T. &Brindle, P.K. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5, 9-15 (2010).
47. Guidez, F. et al. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 25, 5552-5566 (2005).
48. Sankar, N. et al. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27, 5717-5728 (2008).
49. Zhao, L. et al. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb. Nucleic Acids Res. 39, 4664-4679 (2011).
50. Kim, M.Y., Mauro, S., Gévry, N., Lis, J.T. &Kraus, W.L. NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119, 803-814 (2004).
51. Lajugie, J. &Bouhassira, E.E. GenPlay, a multipurpose genome analyzer and browser. Bioinformatics 27, 1889-1893 (2011).
52. Core, L., Waterfall, J. &Lis, J. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322, 1845-1848 (2008).
53. Schefe, J.H., Lehmann, K.E., Buschmann, I.R., Unger, T. &Funke-Kaiser, H. Quantitative real-time RT-PCR data analysis: current concepts and the novel gene expressions CT difference formula. J. Mol. Med. (Berl) 84, 901-910 (2006).
54. Wu, T.D. &Nacu, S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26, 873-881 (2010).
55. Anders, S. &Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
56. Segura, M.F. et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc. Natl. Acad. Sci. USA 106, 1814-1819 (2009).